Stock Track | Harrow Health Plunges 7.99% After Hours on Q1 Earnings Miss and Widened Loss

Stock Track

May 12

Harrow Health Inc's stock experienced a significant after-hours plunge of 7.99%, following the release of its first-quarter 2026 financial results.

The company reported a quarterly loss of $0.74 per share, which missed analyst consensus estimates by 89.74%. Revenue for the quarter came in at $44.2 million, falling short of expectations by 15.68% and representing a 7.59% decline year-over-year. The net loss widened to $27.6 million, while gross margin contracted to 61% from 68% in the same period last year.

Management attributed part of the revenue shortfall to a non-recurring $8 million gross-to-net adjustment related to new commercial coverage for its VEVYE product. Despite the disappointing quarterly results, the company reaffirmed its full-year 2026 revenue guidance of $350 million to $365 million and projected improved second-quarter revenue between $71 million and $81 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1105771376"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1105771376\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1105771376?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-12 04:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105771376","market":"us","top_or_hot":-1,"title":"Stock Track | Harrow Health Plunges 7.99% After Hours on Q1 Earnings Miss and Widened Loss","media":"Stock Track","content":"<p>Harrow Health Inc's stock experienced a significant after-hours plunge of 7.99%, following the release of its first-quarter 2026 financial results.</p><p>The company reported a quarterly loss of $0.74 per share, which missed analyst consensus estimates by 89.74%. Revenue for the quarter came in at $44.2 million, falling short of expectations by 15.68% and representing a 7.59% decline year-over-year. The net loss widened to $27.6 million, while gross margin contracted to 61% from 68% in the same period last year.</p><p>Management attributed part of the revenue shortfall to a non-recurring $8 million gross-to-net adjustment related to new commercial coverage for its VEVYE product. Despite the disappointing quarterly results, the company reaffirmed its full-year 2026 revenue guidance of $350 million to $365 million and projected improved second-quarter revenue between $71 million and $81 million.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Harrow Health Plunges 7.99% After Hours on Q1 Earnings Miss and Widened Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Harrow Health Plunges 7.99% After Hours on Q1 Earnings Miss and Widened Loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-12 04:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Harrow Health Inc's stock experienced a significant after-hours plunge of 7.99%, following the release of its first-quarter 2026 financial results.</p><p>The company reported a quarterly loss of $0.74 per share, which missed analyst consensus estimates by 89.74%. Revenue for the quarter came in at $44.2 million, falling short of expectations by 15.68% and representing a 7.59% decline year-over-year. The net loss widened to $27.6 million, while gross margin contracted to 61% from 68% in the same period last year.</p><p>Management attributed part of the revenue shortfall to a non-recurring $8 million gross-to-net adjustment related to new commercial coverage for its VEVYE product. Despite the disappointing quarterly results, the company reaffirmed its full-year 2026 revenue guidance of $350 million to $365 million and projected improved second-quarter revenue between $71 million and $81 million.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HROW","symbol_name":"Harrow Health Inc","start_time":0,"source_url":"","article_id":"1105771376","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105771376","pubTimestamp":1778531596,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Harrow Health Inc's stock experienced a significant after-hours plunge of 7.99%, following the release of its first-quarter 2026 financial results.The company reported a quarterly loss of $0.74 per...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HROW":"Harrow Health Inc"},"translate_title":"个股追踪|哈罗健康盘后暴跌7.99%因Q1盈利未达预期且亏损扩大","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HROW":1},"content_text":"Harrow Health Inc's stock experienced a significant after-hours plunge of 7.99%, following the release of its first-quarter 2026 financial results.The company reported a quarterly loss of $0.74 per share, which missed analyst consensus estimates by 89.74%. Revenue for the quarter came in at $44.2 million, falling short of expectations by 15.68% and representing a 7.59% decline year-over-year. The net loss widened to $27.6 million, while gross margin contracted to 61% from 68% in the same period last year.Management attributed part of the revenue shortfall to a non-recurring $8 million gross-to-net adjustment related to new commercial coverage for its VEVYE product. Despite the disappointing quarterly results, the company reaffirmed its full-year 2026 revenue guidance of $350 million to $365 million and projected improved second-quarter revenue between $71 million and $81 million.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}